Free Trial

SNDL (SNDL) Competitors

SNDL logo
$2.63 -0.02 (-0.75%)
Closing price 10/8/2025 04:00 PM Eastern
Extended Trading
$2.63 0.00 (0.00%)
As of 04:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

SNDL vs. ACB, CGC, CRON, OGI, TLRY, KNSA, APLS, MOR, GMTX, and IMVT

Should you be buying SNDL stock or one of its competitors? The main competitors of SNDL include Aurora Cannabis (ACB), Canopy Growth (CGC), Cronos Group (CRON), Organigram Global (OGI), Tilray Brands (TLRY), Kiniksa Pharmaceuticals International (KNSA), Apellis Pharmaceuticals (APLS), MorphoSys (MOR), Gemini Therapeutics (GMTX), and Immunovant (IMVT). These companies are all part of the "pharmaceutical products" industry.

SNDL vs. Its Competitors

Aurora Cannabis (NASDAQ:ACB) and SNDL (NASDAQ:SNDL) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, media sentiment, risk, valuation, profitability and analyst recommendations.

SNDL has a consensus target price of $4.50, indicating a potential upside of 71.10%. Given SNDL's higher probable upside, analysts clearly believe SNDL is more favorable than Aurora Cannabis.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aurora Cannabis
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80
SNDL
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Aurora Cannabis had 1 more articles in the media than SNDL. MarketBeat recorded 5 mentions for Aurora Cannabis and 4 mentions for SNDL. Aurora Cannabis' average media sentiment score of 1.27 beat SNDL's score of -0.27 indicating that Aurora Cannabis is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aurora Cannabis
3 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
SNDL
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Aurora Cannabis has a beta of 1.75, suggesting that its share price is 75% more volatile than the S&P 500. Comparatively, SNDL has a beta of 3.83, suggesting that its share price is 283% more volatile than the S&P 500.

Aurora Cannabis has a net margin of -5.66% compared to SNDL's net margin of -10.38%. Aurora Cannabis' return on equity of -1.49% beat SNDL's return on equity.

Company Net Margins Return on Equity Return on Assets
Aurora Cannabis-5.66% -1.49% -1.06%
SNDL -10.38%-8.58%-7.23%

47.6% of Aurora Cannabis shares are owned by institutional investors. 0.0% of Aurora Cannabis shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Aurora Cannabis has higher earnings, but lower revenue than SNDL. Aurora Cannabis is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aurora Cannabis$246.72M1.39$1.63M-$0.19-32.11
SNDL$671.81M1.03-$69.18M-$0.27-9.74

Summary

Aurora Cannabis beats SNDL on 12 of the 16 factors compared between the two stocks.

Get SNDL News Delivered to You Automatically

Sign up to receive the latest news and ratings for SNDL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SNDL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SNDL vs. The Competition

MetricSNDLMED PRODUCTS IndustryMedical SectorNASDAQ Exchange
Market Cap$696.36M$10.57B$6.10B$10.55B
Dividend YieldN/A1.87%5.69%4.75%
P/E Ratio-9.7421.8785.6027.60
Price / Sales1.0332.51538.21205.12
Price / CashN/A25.4637.9261.55
Price / Book0.833.4513.246.76
Net Income-$69.18M$208.83M$3.30B$275.88M
7 Day Performance3.95%1.63%4.35%2.81%
1 Month Performance8.68%2.06%9.51%9.24%
1 Year Performance34.87%-5.12%88.04%35.42%

SNDL Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SNDL
SNDL
3.1072 of 5 stars
$2.63
-0.8%
$4.50
+71.1%
+35.6%$696.36M$671.81M-9.742,516Analyst Forecast
ACB
Aurora Cannabis
0.6125 of 5 stars
$6.23
+28.2%
N/A+13.0%$350.25M$246.72M-32.791,130News Coverage
Analyst Upgrade
Gap Up
High Trading Volume
CGC
Canopy Growth
0.6314 of 5 stars
$1.57
+17.2%
N/A-62.6%$376.56M$225.65M-0.523,150Analyst Forecast
High Trading Volume
CRON
Cronos Group
1.0741 of 5 stars
$2.97
+12.9%
N/A+23.5%$1.14B$117.61M59.40450Analyst Forecast
High Trading Volume
OGI
Organigram Global
0.7257 of 5 stars
$1.97
+16.6%
N/A+14.1%$264.65M$117.47M39.41860Analyst Forecast
High Trading Volume
TLRY
Tilray Brands
2.0469 of 5 stars
$1.85
+60.9%
$1.94
+4.7%
+4.2%$2.04B$821.31M-0.802,842Trending News
Analyst Forecast
High Trading Volume
KNSA
Kiniksa Pharmaceuticals International
3.649 of 5 stars
$38.77
+6.2%
$44.29
+14.2%
+56.6%$2.87B$423.24M969.49220Analyst Downgrade
APLS
Apellis Pharmaceuticals
4.1533 of 5 stars
$22.65
+1.3%
$33.29
+47.0%
-9.1%$2.86B$781.37M-12.44770Analyst Forecast
MOR
MorphoSys
N/A$18.96
flat
N/AN/A$2.86B$238.28M-5.45730
GMTX
Gemini Therapeutics
N/A$65.55
+4.9%
N/A+43.4%$2.84BN/A-65.5530
IMVT
Immunovant
1.8768 of 5 stars
$16.06
-1.0%
$33.60
+109.2%
-45.7%$2.80BN/A-5.64120

Related Companies and Tools


This page (NASDAQ:SNDL) was last updated on 10/9/2025 by MarketBeat.com Staff
From Our Partners